Stock Market Today: All You Need To Know Going Into Trade On May 31
Stocks in the news, big brokerage calls of the day, complete trade setup and much more!
Stocks in Asia fell Tuesday amid concerns on the impact on growth due to interest rate hikes by central banks and the surge in crude oil prices to $118 per barrel after the European Union backed a push to ban some Russian oil.
Equities in Japan, Korea and Australia declined while Hong Kong futures fell. U.S. contracts rose. American markets were shut Monday for the Memorial Day holiday.
The Singapore-traded SGX Nifty, an early barometer of India's benchmark Nifty 50, fell 0.14% to 16,623 points as of 6:20 am. India's GDP data for quarter-ended March and estimate for FY22, fiscal deficit data and core output data for April are scheduled to be released today.
European bonds fell as German inflation hit a record. The dollar rose slightly. U.S. President Joe Biden will hold a rare Oval office meeting on Tuesday with Fed Chair Jerome Powell amid rising inflation and ahead of US payroll numbers later this week. Elsewhere, Bitcoin was back above $31,000.
Earnings Post Market Hours
LIC Q4 FY22 (Consolidated, YoY)
Revenue up 12% at Rs 2,12,230 crore Vs 1,90,099 crore
EBITDA at Rs 2,396 crore Vs Rs 2,921 crore, down 18%
EBITDA margins at 1.13% vs 1.54%
Net profit down 17% of Rs 2,409 crore Vs Rs 2,917 crore
EPS at Rs 3.81 vs Rs 4.61
Recommended dividend of Rs 1.5 per share of face value Rs 10 each
Sun Pharmaceuticals Q4 FY22 (Consolidated, YoY)
Revenue up 11% at Rs 9,447 crore Vs Rs 8,523 crore (Bloomberg estimate: Rs 9,576 crore)
EBITDA up 6% to Rs 2,179 crore from Rs 2,059 crore (Bloomberg estimate: Rs 2,544 crore)
EBITDA margins at 23.1% Vs 24.2% (Bloomberg estimate: 26.6%)
Net loss of Rs 2,277 crore Vs net profit of Rs 894 crore (Bloomberg estimate: Rs 1,707 crore Profit)
Recommended final dividend of Rs 3 per share of face value Re 1 each
Approved merger of its wholly owned subsidiaries Sun Pharmaceutical Medicare, Green Eco Development Centre, Faststone Mercantile, Realstone Multitrade and Skisen Labs with the company.
Aurobindo Pharma Q4 FY22 (Consolidated, YoY)
Revenue down 3% at Rs 5,809 crore Vs Rs 6,002 crore (Bloomberg estimate: Rs 5,901 crore)
EBITDA down 24% to Rs 974 crore from Rs 1,275 crore (Bloomberg estimate: Rs 1,029 crore)
EBITDA margins at 16.8% Vs 21.2% (Bloomberg estimate: 17.4%)
Net profit down 28% to Rs 576 crore Vs Rs 802 crore (Bloomberg estimate: Rs 600 crore)
Approved fourth interim dividend of Rs 4.5 per share of face value of Rs 1 each
Jindal Steel and Power Q4 FY22 (Consolidated, YoY)
Revenue up 35% at Rs 14,339.49 crore Vs Rs 10,593.72 crore (Bloomberg estimate: Rs 14,900.9 crore)
EBITDA fell 38% at Rs 3,070.2 crore Vs Rs 4,963.61 crore (Bloomberg estimate: Rs 3,854.4 crore)
EBITDA margin 21.41% Vs 46.85% (Bloomberg estimate: 25.86%)
Net profit up 3% at Rs 2,206.97 crore Vs Rs 2,139.28 crore (Bloomberg estimate: Rs 1,999.8 crore)
Recommended final dividend of Rs 2 per share of face value of Re 1.
IRCTC Q4 FY22 (Consolidated, QoQ)
Revenue up 28% at Rs 690.96 crore Vs Rs 540.21 crore
EBITDA fell 2% at Rs 264.35 crore Vs Rs 268.98 crore
EBITDA margin 38.3% Vs 49.8%
Net profit up 2% at Rs 213.78 crore Vs Rs 208.8 crore
Recommended final dividend of Rs 1.5 per share of face value of Rs 2 each
Trident Q4 FY22 (Consolidated, YoY)
Revenue up 37% at Rs 1,847.14 crore Vs Rs 1,350 crore
EBITDA up 40% at Rs 327.57 crore Vs Rs 235.56 crore
EBITDA margin 17.73% Vs 17.45%
Net profit up 130% at Rs 173.55 crore Vs Rs 75.63 crore
Dilip Buildcon Q4 FY22 (Consolidated, YoY)
Revenue fell 15% at Rs 2,663.7 crore Vs Rs 3,135.47 crore
EBITDA fell 62.5% at Rs 218.63 crore Vs Rs 584.33 crore
EBITDA margin 8.21% Vs 18.64%
Net loss up 58% at Rs 41.09 crore Vs Rs 96.9 crore
Appointed Sanjay Kumar Bansal as the Chief Financial Officer with effect from May 31.
Rail Vikas Nigam Q4 FY22 (Consolidated, YoY)
Revenue up 15% at Rs 6,437.54 crore Vs Rs 5,577.92 crore
EBITDA up 15% at Rs 408.38 crore Vs Rs 354.07 crore
EBITDA margin 6.34% Vs 6.35%
Net profit fell 1% at Rs 378.16 crore Vs Rs 381.79 crore
Delhivery Q4 FY22 (Consolidated, QoQ)
Revenue up 4% at Rs 2,071.75 crore Vs Rs 1,995.04 crore
EBIT fell 20% at negative Rs 159.32 crore Vs negative Rs 132.38 crore
EBIT margin -7.69% Vs -6.64%
Net loss fell 5% at Rs 119.86 crore Vs Rs 126.51 crore
NBCC (India) Q4 FY22 (Consolidated, YoY)
Revenue fell 11% at Rs 2,441.04 crore Vs Rs 2,752.63 crore
EBITDA fell 8.5% at Rs 72.98 crore Vs Rs 79.7 crore
EBITDA margin 3% Vs 2.9%
Net profit fell 57% at Rs 35.38 crore Vs Rs 82.36 crore
NLC India Q4 FY22 (Consolidated, YoY)
Revenue up 9% at Rs 3,085.89 crore Vs Rs 2,839.55 crore
EBITDA up 26.5% at Rs 1,068.74 crore Vs Rs 845.13 crore
EBITDA margin 34.6% Vs 29.7%
Net profit fell 54% at Rs 331.16 crore Vs Rs 725.5 crore
Radico Khaitan Q4 FY22 (Consolidated, YoY)
Revenue up 9.5% at Rs 3,224.45 crore Vs Rs 2,946.43 crore
EBITDA fell 21.5% at Rs 79.61 crore Vs Rs 101.35 crore
EBITDA margin 2.5% Vs 3.4%
Net profit fell 32% at Rs 50.15 crore Vs Rs 73.53 crore
Recommended final dividend of Rs 3 per share of face value of Rs 2 each
Dish TV India Q4 FY22 (Consolidated, QoQ)
Revenue fell 10% at Rs 642.7 crore Vs Rs 710.67 crore
EBIT fell 37% at Rs 114.95 crore Vs Rs 181.92 crore
EBIT margin 17.9% Vs 25.6%
Net loss of Rs 2,032 crore Vs net profit of 8,021 crore. Loss includes impairment of assets of Rs 2,653.88 crore. Profit before exceptional items and tax stood at Rs 41.82 crore
Campus Activewear Q4 FY22 (Consolidated, YoY)
Revenue up 28% at Rs 352.33 crore Vs Rs 275.1 crore
EBITDA up 21% at Rs 78.40 crore Vs Rs 65.03 crore
EBITDA margin 22.25% Vs 23.64%
Net profit up 296% at Rs 39.6 crore Vs Rs 10 crore
Medplus Health Services Q4 FY22 (Consolidated, QoQ)
Revenue up 3.5% at Rs 965.9 crore Vs Rs 933.45 crore
EBIT fell 21% at Rs 50.36 crore Vs Rs 63.43 crore
EBIT margin 5.21% Vs 6.8%
Net profit fell 32% at Rs 11.43 crore Vs Rs 16.91 crore
Stock To Watch
Mahindra & Mahindra: The company sold 2.76% stake in TVS Automobile Solutions for Rs 45 crore.
MPS: The company completed acquisition of EI Designs through MPS Interactive Systems, its wholly owned subsidiary for Rs 40 crore.
Lemon Tree Hotels: The company has signed a license agreement for a 40 room hotel at Chirang, Assam under its brand ‘Keys Select, by Lemon Tree Hotels.’ The hotel is expected to be operational by June, 2026.
Earnings: PTC India
Pledged Shares Details
Emami: Promoter Group Sneha Enclave created a pledge of 4.5 lakh shares on May 25 and revoked a pledge of 1.25 lakh shares on May 26. Promoter Group Suraj Finvest created a pledge of 2.85 lakh shares on May 25. Promoter Group Midkot Investments revoked a pledge of 75,000 shares on May 26.
Insider Trades
NXTdigital: Promoter Group Aasia Corporation sold 7 lakh shares on May 26. Promoter Hinduja Group bought 7 lakh shares on May 26.
Zensar Technologies: Promoter Group Sofreal Mercantrade bought 31,812 shares between May 26 and May 27. Promoter Group Summit Securities bought 5,700 shares on May 26. Promoter Group Instant Holdings bought 76,272 shares on May 27.
Ultramarine & Pigments: Promoter Group S Narayan sold 1,100 shares between May 27 and May 28. Promoter Group Deepa Ajay sold 2,172 shares between May 27 and May 28. Promoter Daya Sridhar sold 2,600 shares between May 27 and May 28.
Anant Raj: Promoter Group Roma Sarin bought 52,200 shares on May 27.
Manappuram Finance: Promoter & Director Nandakumar VP bought 2.19 lakh shares on May 27.
Orient Cement: Promoter Central India Industries bought 28,000 shares between May 26 and May 27. Promoter Shekhavati Investments and Traders bought 28,138 shares between May 26 and May 27.
Mastek: Promoter & Director Ashank Desai bought 4,000 shares on May 25.
KEC International: Promoter Group Summit Securities bought 16,500 shares on May 26. Promoter Group Instant Holdings bought 1,000 shares on May 26 and 15,647 shares on May 27.
Bulk Deal
Shalby: Shalby Limited Employees Welfare Trust bought 7 lakh (0.64%) shares and Shalby Medicos Trust sold 7 lakh (0.64%) shares each at Rs 107.5 apiece.
Who's Meeting Whom
Fermenta Biotech: To meet investors and analysts on June 1.
Jindal Saw: To meet investors and analysts on June 1.
HEG: To meet investors and analysts on June 2.
Hindustan Oil Exploration Company: To meet investors and analysts on June 2.
Arman Financial Services: To meet investors and analysts on June 2.
IOL Chemicals and Pharmaceuticals: To meet investors and analysts on June 1.
VIP Industries: To meet ICICI Prudential MF, PGIM India Mutual Fund, SBI MF and LIC MF on June 1.
Indoco Remedies: To meet UTI MF, ABSL MF and ICICI Prudential MF on June 2.
Aegis Logistics: To meet investors and analysts on May 31.
Mrs. Bectors Food Specialties: To meet investors and analysts on June 6.
Bayer CropScience: To meet investors and analysts on June 3.
Krsnaa Diagnostics: To meet investors and analysts on June 2.
HDFC Bank: To meet analysts on May 31.
Infosys: To meet investors and analysts on May 31.
NBCC (India): To meet investors and analysts on June 2.
Khadim India: To meet investors and analysts on June 2.
Dhani Services: To meet investors and analysts on May 31.
Trading Tweaks
Price Band Revised From 20% To 10%: Godawari Power and Ispat
Ex-Date Dividend: Housing Development Finance Corporation, HDFC Life Insurance Company
Ex-Date Annual General Meeting/Dividend: Infosys
Ex-Date Income Distribution: POWERGRID Infrastructure Investment Trust
Move Into Short-Term ASM Framework: Godawari Power and Ispat, Lumax Industries
Move Out Of Short-Term ASM Framework: Elgi Equipments, Triveni Engineering & Industries, Nava Bharat Ventures
Money Market Update
The rupee ended at Rs 77.54 against the U.S. Dollar on Monday as compared to Friday's closing of 77.57
F&O Cues
Nifty June futures ended at 16,651.20, a discount of 10.20 points.
Nifty June futures added 1.97% and 4,438 shares in Open Interest.
Nifty Bank June futures ended at 35,889, a premium of 62.05 points.
Nifty Bank June futures added 2.32% and 2,119 shares in Open Interest.